Portal de Periódicos da CAPES

Community Pharmacists in Taiwan at the Frontline Against the Novel Coronavirus Pandemic: Gatekeepers for the Rationing of Personal Protective Equipment

2020; American College of Physicians; Volume: 173; Issue: 2 Linguagem: Inglês

10.7326/m20-1404

1539-3704

Huang‐Tz Ou, Yea‐Huei Kao Yang,

COVID-19 and healthcare impacts

Ideas and Opinions13 April 2020Community Pharmacists in Taiwan at the Frontline Against the Novel Coronavirus Pandemic: Gatekeepers for the Rationing of Personal Protective EquipmentFREEHuang-Tz Ou, PhD and Yea-Huei Kao Yang, BS PharmHuang-Tz Ou, PhDNational Cheng Kung University, Tainan, Taiwan (H.O., Y.K.Y.) and Yea-Huei Kao Yang, BS PharmNational Cheng Kung University, Tainan, Taiwan (H.O., Y.K.Y.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/M20-1404 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail As one of the earliest countries to activate public health measures, Taiwan has felt a more moderate effect of the coronavirus disease 2019 (COVID-19) pandemic than many other countries. It has had relatively few infections: As of 8 April 2020, there were 379 confirmed cases with 5 deaths in Taiwan, compared with 1 371 189 cases with 80 522 deaths globally. Imported COVID-19 cases have constituted most infections in Taiwan (326 imported vs. 53 locally acquired), suggesting that community outbreaks have been less frequent. Other proactive measures undertaken by the Taiwanese government have included strengthening quarantine measures at ports of entry, retrospectively identifying potential COVID-19 cases, and identifying new infection patterns or symptoms and clustered cases to promptly track potential infection sources or paths. The government has also aggressively enforced rules about mask wearing, self-quarantine, and social distancing (1).During the severe acute respiratory syndrome epidemic in 2003, public demand surged in Taiwan for personal protective equipment, such as surgical masks; these are seen as must-have equipment, and demand for masks reflects people's fear during a public health crisis. In response to a shortage of surgical masks due to the COVID-19 outbreak, in late January 2020 the Taiwanese government imposed a ban on the export of surgical masks and requisitioned all domestically produced masks. In early February 2020, the government implemented a rationing system for distributing surgical masks to prevent panic buying (2). This system uses multilayer logistics to ensure quick and efficient implementation. It integrates the manufacturing sector, National Health Insurance (NHI) system, information and communication technology, and logistics of delivery and distribution to ensure that all citizens receive masks while prioritizing the allocation of sufficient masks to health care personnel. Surgical mask production was quickly scaled up in early April 2020 to 13 million masks a day for Taiwan's population of 23.8 million to allow for an increase in the individual allowance to 10 masks every 2 weeks.Community pharmacies, which are strategically located and have NHI-integrated information systems, were given the responsibility of distributing and rationing masks directly to the public. A real-time, open tracking system for mask availability was immediately implemented at each pharmacy using website and mobile applications to guide citizens in need of masks. The system included online chatbots and voice assistants that provided information about the supply of masks and the locations of the 6515 NHI-contracted pharmacies across the nation. Community pharmacists repacked the bulk packages of masks into unit packets containing the rationed amount and completed the NHI online procedures for residents in their communities. Often serving as the first point of contact between individuals and the health care system, community pharmacists offered education and consultation on proper hygiene strategies, disseminated accurate information to counter myths and misinformation, and provided emotional support to alleviate public concerns arising from the COVID-19 crisis. At this time, dispensing services provided in community pharmacies have been particularly crucial in minimizing the potential for a large influx of patients seeking prescriptions from hospital pharmacies.At the same time, physicians and nurses in community-based primary care clinics have played a critical role in the early identification of potential COVID-19 cases by examining patients with clinical symptoms, obtaining their history of travel or transit in affected countries or areas (which can be accessed from the patients' NHI identification cards), and referring suspected case patients to government-designated hospitals in a timely fashion. Stringent policies have been implemented to control access to Taiwanese hospitals. Unessential visits have been suspended, and persons with any signs or symptoms of COVID-19 are directed to an outdoor quarantine station for evaluation or the emergency department for isolation in negatively pressurized rooms (3). Other measures have included the strict diversion and transport of patients with COVID-19 to different levels of hospitals on the basis of the severity of their symptoms and the segregation of hospital wards to ensure appropriate patient care (4).During this pandemic, several challenges to community pharmacists have emerged. Small independent pharmacies with limited manpower had difficulty using the rationing system for mask purchases. Taiwan's pharmacy organizations, in collaboration with pharmacy schools, have provided timely support to independent pharmacies by arranging for student volunteers to help repack masks for purchases and prepare and deliver educational materials. Small pharmacies have had difficulty managing the large influx of citizens seeking services, some of whom are extremely anxious. Some village chiefs have assisted neighborhood pharmacies in managing emotional or angry customers.Some have suggested that professional organizations and health authorities should invest in ensuring that pharmacists have the essential skills needed to respond to future public health emergencies (5). The provision of COVID-19–related services, which gives little to no monetary compensation, can interfere with routine pharmacy practices, and an optimal business model for pharmacies during this period (including minimizing promotional activities and encouraging electronic payments) has been recommended (6). Large crowds seeking prevention and control strategies or products in pharmacies may create risk for virus transmission (6). In Taiwan, an online service platform for purchasing surgical masks from governmental websites has been developed to relieve overcrowding in pharmacies and reduce virus transmission. On the other hand, some Taiwanese hospitals have encouraged patients to return for prescription refills at their outpatient pharmacies, potentially increasing risk for exposure to the infection. The government and pharmacy associations have responded by urging the public to maximize their use of services provided by community pharmacists during this crisis. Finally, drug shortages are a potential problem due to the recent supply chain disruptions caused by the lockdown of manufacturers in areas affected by COVID-19. Identifying alternative drugs and minimizing requests for no substitution are potential solutions to mitigate this problem (6).In this unprecedented global public health emergency, a reliable network of health care professionals in communities near where people live is vital for providing services and products for self-care and reducing anxiety and panic. This COVID-19 crisis is the moment for community health care workers to step up to the plate and show their value in public health.References1. Taiwan Centers for Disease Control. Press releases. Accessed at www.cdc.gov.tw/En/Bulletin/List/7tUXjTBf6paRvrhEl-mrPg on 8 April 2020. Google Scholar2. Taiwan Centers for Disease Control. Name-based rationing system for purchases of masks to be launched on February 6; public to buy masks with their (NHI) cards. 4 February 2020. Accessed at www.cdc.gov.tw/En/Bulletin/Detail/ZlJrIunqRjM49LIBn8p6eA?typeid=158 on 8 April 2020. Google Scholar3. Lee IK, Wang CC, Lin MC, et al. Effective strategies to prevent coronavirus disease-2019 (COVID-19) outbreak in hospital [Letter]. J Hosp Infect. 2020. [PMID: 32142886] doi:10.1016/j.jhin.2020.02.022 CrossrefMedlineGoogle Scholar4. Taiwan Centers for Disease Control. CECC maintains six strategies to prevent COVID-19 spread in hospitals. 7 April 2020. Accessed at www.cdc.gov.tw/En/Bulletin/Detail/pOahsDWblKw6KMVDsPed9Q?typeid=158 on 8 April 2020. Google Scholar5. Wiedenmayer K, Summers RS, Mackie CA, et al. Developing pharmacy practice: a focus on patient care: handbook. No. WHO/PSM/PAR/2006.5. World Health Organization; 2006. Google Scholar6. International Pharmaceutical Federation. SARS-CoV-2 infection: expert consensus on guidance and prevention and control strategies for retail pharmacy workforce (1st edition). 2020. Accessed at www.fip.org/files/content/priority-areas/coronavirus/English_SARS-CoV-2_Infection_Expert_Consensus_on_Guidance_and_Prevention_and_Control_Strategies_for_Retail_Pharmacy_Workforce.pdf on 8 April 2020. Google Scholar Comments 0 Comments Sign In to Submit A Comment Kevin Sheng-Kai Ma, Alice Shin-Yi TsaiDepartment of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.14 May 2020 Big Data-driven personal protective equipment stockpiling framework under Universal Healthcare for Disease Control and Prevention in the COVID-19 Era Big data analytics has improved healthcare by analyzing electronic medical records, socio-demographic information, and environmental factors [1]; moreover, its tracking roles in emerging infectious diseases including the coronavirus pandemic have been discussed [2]. In countries with single-payer universal healthcare systems (UHS), claimed data of payers could be an abundant source for analytics. On the other hand, compulsory social distancing, coupled with mass masking, has been widely adopted as strategy for non-specific symptoms at early stage COVID-19 [3]. We propose that analytics based on proper concatenation of databases may prevent supply shortages for personal protective equipment (PPEs). Taking Taiwan as an example, cloud computing-based healthcare databases within the UHS has alleviated the integration between primary care providers and hospitals, as well as reduced the cost of tracking procedure. Applying the same logistics to PPE allocation would allow PPE providers to manage the distribution of surgical masks on a real-time basis, and recognize the mask holders per insurance or passport number [4]. With the help of data analysis, combining artificial intelligence and cloud technology, public health policy-making could be practicable. Thus when it comes to the implementation cost of epidemic prevention policies, Taiwan authorities adopt low stringent level strategies compared with other high income countries, but still have achieved epidemic control in the early outbreak [5]. After the 2003 severe acute respiratory syndrome outbreak, Taiwan CDC (TCDC) started transferring registered real-time infectious disease data to this established monitoring system, where PPE stockpiling platform was practiced. Therefore, prior to the official recognition of COVID-19 outbreak [2], PPE databases were subsequently concatenated by UHS to manage resource allocation and logistics when several cases were identified. Establishment of this application programming interface for mask-selling pharmacies under UHS required data transfers as well as managerial issues including governance and ownership, which interdepartmental communication was efficient within UHS. Specifically, the tracking system expands the healthcare informatics system that pharmacists are familiar with, which user friendly interfaces for these PPE providers and consumers help expedite processes in an efficient manner [4]. UHS and TCDC have also promoted the system to increase the distribution channels, which government offices may also allot masks to lessen the burden on healthcare providers. Since masks alone aren't effective without combining infection-control measures [6], we recommend to utilize such integrative platform for the maintenance of more PPE stockpiles, including critical infection-control equipments, so as to reduce iatrogenic COVID-19 exposure. [1] Kevin Vigilante, Steve Escaravage, and Mike McConnell. Big Data and the Intelligence Community — Lessons for Health Care. N Engl J Med 2019; 380:1888-1890 [2] C. Jason Wang, Chun Y. Ng, Robert H. Brook. Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing. JAMA. 2020; 323(14): 1341-1342. [3] Megan L. Ranney, Valerie Griffeth, and Ashish K. Jha. Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. N Engl J Med 2020; 382:e41. DOI: 10.1056/NEJMp2006141 [4] NHCC [National Health Command Center]. Taiwan Centers for Disease Control. Updated February 1, 2018. Accessed May 6, 2020. https://www.cdc.gov.tw/En/Category/MPage/gL7-bARtHyNdrDq882pJ9Q [5] Hale, Thomas, Sam Webster, Anna Petherick, Toby Phillips, and Beatriz Kira (2020). Oxford COVID-19 Government Response Tracker, Blavatnik School of Government. Data use policy: Creative Commons Attribution CC BY standard. [6] Klompas M, Morris CA, Sinclair J, Pearson M, Shenoy ES. Universal masking in hospitals in the Covid-19 era. N Engl J Med. DOI: 10.1056/NEJMp2006372 Author, Article, and Disclosure InformationAuthors: Huang-Tz Ou, PhD; Yea-Huei Kao Yang, BS PharmAffiliations: National Cheng Kung University, Tainan, Taiwan (H.O., Y.K.Y.)Acknowledgment: The authors thank Swu-Jane Lin and Shihchen Kuo for their help in preparing and drafting the manuscript.Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-1404.Corresponding Author: Yea-Huei Kao Yang, BS Pharm, School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, 1 University Road, Tainan 701, Taiwan; e-mail, yhkao@mail.ncku.edu.tw.Current Author Addresses: Drs. Ou and Kao Yang: School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, 1 University Road, Tainan 701, Taiwan.Author Contributions: Conception and design: H.T. Ou, Y.H. Kao Yang.Analysis and interpretation of the data: H.T. Ou.Drafting of the article: H.T. Ou.Critical revision of the article for important intellectual content: H.T. Ou, Y.H. Kao Yang.Final approval of the article: H.T. Ou, Y.H. Kao Yang.Administrative, technical, or logistic support: H.T. Ou, Y.H. Kao Yang.Collection and assembly of data: H.T. Ou.This article was published at Annals.org on 13 April 2020. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA photovoice study on community pharmacists' roles and lived experiences during the COVID-19 pandemicHow Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020–2022Chatbots in Pharmacy: A Boon or a Bane for Patient Care and Pharmacy Practice?Impact of the Novel CoronaviruS (COVID-19) on Frontline PharmacIsts Roles and ServicEs: INSPIRE Worldwide SurveyMapping Real-World Data to Self-Reported Information to Explore Determinants of Location Selection for Community Pharmacies in TaiwanUsing the Kano model to associate the number of confirmed cases of COVID-19 in a population of 100,000 with case fatality rates: An observational studySeasonal influenza vaccination in pharmacy in France: description and determinants of the vaccinated at-risk population using this service, 1 year after implementationExpanded roles of community pharmacists in COVID-19: A scoping literature reviewA comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to futureEczacılarda Covid-19 ve tedavisine yönelik bilgi düzeyi ölçülmesiCommunity pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacistsRole of the pharmacist during the COVID-19 pandemic: a time to rethink strategiesCOVID the Catalyst for Evolving Professional Role Identity? A Scoping Review of Global Pharmacists' Roles and Services as a Response to the COVID-19 PandemicManaging medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the futureThe impact of COVID-19 on the research and educational environment in Taiwan -forewarned is forearmedRole of pharmacist during the COVID-19 pandemic: A scoping reviewThe pharmaceutical practice of mask distribution by pharmacists in Taiwan's community pharmacies under the Mask Real-Name System, in response to the COVID-19 outbreakThree Taiwan's domestic family cluster infections of coronavirus disease 2019The Pharmacists' Role in Disease Outbreaks: Navigating the Dynamics of Uncertainty Before, During, and After Disease Outbreaks 21 July 2020Volume 173, Issue 2 Page: 149-150 Keywords COVID-19 Health care Health information technology Health insurance Information technology Outpatient clinics Personal protective equipment Pharmacists Prevention, policy, and public health Quarantines ePublished: 13 April 2020 Issue Published: 21 July 2020 Copyright & PermissionsCopyright © 2020 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...